Best Practices in Biotechnology Business Development - Valuation,
Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication,
and Intellectual Property
ADVERTISE HERE 

This newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents

Drug Patent Expirations for July 28 2010

TradenameApplicantGeneric NamePatent Number Patent Expiration
IMODIUM MULTI-SYMPTOM RELIEFMcneilloperamide hydrochloride; simethicone5,248,505Jul 28, 2010

*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.


SUBSCRIPTIONS

If this newsletter has been forwarded to you and you would like to receive regular updates by email, go to http://www.DrugPatentWatch.com/newsletter


The above list does not discriminate between dominant and non-dominant patents. Drugs listed above may be protected by additional patents and other regulatory protections. See the DrugPatentWatch database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
All trademarks and applicant names are the property of their respective owners or licensors.